Moderna and Pfizer are both developing COVID-19 vaccines specifically designed to protect against the Omicron strain.
And Australia is experiencing a surge in people suffering from long COVID, so what are the treatment options?
Morningshow etc.
RN Breakfast - Separate stories podcast Folgen
RN Breakfast daily stories separated out for easy listening. RN Breakfast is the program informed Australians wake up to. Start each day with comprehensive coverage and analysis of national and international events, and hear interviews with the people who matter today—along with those who'll be making news tomorrow.
Folgen von RN Breakfast - Separate stories podcast
247 Folgen
-
Folge vom 04.07.2022Variant vaccines and treatments for long COVID - Health with Tegan Taylor
-
Folge vom 04.07.2022Artists fear new job assistance programArtists and arts workers fear they will be unfairly impacted by the Federal Government's new job assistance program, which comes into effect on Monday. Workforce Australia is an online points based system for mutual obligation under Jobseeker but arts work is not recognised by Centrelink.
-
Folge vom 04.07.2022Nick Kyrgios causes a stir at WimbledonAussie tennis star Nick Kyrgios has advanced to the Wimbledon Round of Sixteen, after an impressive but controversial victory over fourth seed Stefanos Tsitsipas. Tsitsipas and Kyrgios were both fined for offences they perpetrated during the heated Wimbledon match.
-
Folge vom 04.07.2022Calls for 4th booster as fresh COVID wave loomsAs Australia braces for another wave of COVID-19 infections, some epidemiologists say health authorities should consider approving a fourth booster shot for the entire adult population. Pfizer and Moderna are both working on vaccines designed to protect against the Omicron variant, but they're not expected to be available for months.